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1. Introduction 
The first evidence that altered intracellular Ca2+ homeostasis is causally involved in 
ventricular tachyarrhythmias was revealed by investigations of the pathophysiology of 
digitalis intoxication (Ferrier et al., 1973; Rosen et al., 1973). More recently, spontaneous Ca2+ 
release from the sarcoplasmic reticulum (SR) through the cardiac ryanodine receptor (RyR2) 
has been found to play a fundamental role in the generation of lethal arrhythmias. Such 
arrhythmias occur in both acquired forms of cardiac diseases (e.g., heart failure, atrial 
fibrillation) and in a number of congenital arrhythmia syndromes associated with mutations 
of RyR2 or calsequestrin1, such as cathecholaminergic polymorphic ventricular tachycardia 
(CPVT2). The currently incomplete understanding of the mechanism underlying disrupted 
Ca2+ regulation in arrhythmogenesis in heart failure has led scientists to the consideration 
that CPVT as a simplified human and experimental model may help to clarify the disruption 
of Ca2+ homeostasis as a substrate for triggered activity (Priori & Napolitano, 2005). 
Therefore, a better understanding of the similarities and differences between the 
mechanisms underlying triggered arrhythmias in acquired and inherited cardiac diseases, 
holds the promise to develop new specific diagnostic and therapeutic approaches for 
effective treatment of defective ion handling. 
In this chapter, we will review common mechanisms that cause the susceptibility to, and 
initiation of, Ca2+-dependent arrhythmias with a focus on increased SR Ca2+ release due to 
congenital or acquired RyR2 dysfunction and increased SR Ca2+ load. Finally, RyR2 
stabilizers and Ca2+/calmodulin-dependent protein kinase II (CaMKII) inhibitors as novel 
therapeutic targets will be discussed. 
2. Altered Ca
2+
 homeostasis is an arrhythmogenic substrate 
In a normal cardiac myocyte, Ca2+ couples electrical activation (action potential) to 
mechanical activity (contraction and relaxation) through a process referred to as excitation-
contraction coupling. The cardiac cycle begins with membrane depolarization, which activates 
L-type voltage-gated Ca2+ channels resulting in a Ca2+ influx. This small elevation of 
cytosolic [Ca2+] binds to the RyR2. The RyR2 opens, resulting in a larger Ca2+ release from 
                                                 
1 SR Ca2+ buffer protein 
2 Induced by emotional stress or physical activity in the absence of structural heart disease 
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the SR, a phenomenon termed calcium-induced calcium release (Endo, 1977). Using confocal 
microscopy with Ca2+-sensitive dyes, the opening of individual RyR2 clusters can be 
visualized as brief increases of [Ca2+]i, called Ca2+ sparks (Cheng et al., 1993). SR Ca2+ release 
units are normally synchronized to release Ca2+ simultaneously. Ca2+ release from the SR is 
the major source of Ca2+ required for excitation-contraction coupling. The whole process of 
Ca2+ movement is characterized by a transient increase in intracellular [Ca2+] from 100 nM 
(resting or diastolic Ca2+) to about 1 M (systolic Ca2+), which initiates the contraction (Bers, 
2001). Relaxation is initiated by the termination of SR Ca2+ release, of which mechanisms are 
complex and rather controversial. These mechanisms include RyR2 adaptation, RyR2 
inactivation, SR Ca2+ depletion and luminal regulation of the RyR2 (Stern & Cheng, 2004). 
Ca2+ then dissociates from troponin C and is recycled into the SR through phospholamban-
regulated SR Ca2+-ATPase (SERCA2a) and removed from the cells via the Na+/Ca2+ 
exchanger across the sarcolemmal membrane (Bers, 2002). The orchestrated interplay 
between these Ca2+ fluxes within different compartments is a prerequisite for the 
maintenance of Ca2+ homeostasis and ultimately, the heart rhythm. However, spontaneous 
Ca2+ release from the SR (also called Ca2+ leak) between two consecutive Ca2+ cycles will 
alter Ca2+ homeostasis and generate an arrhythmogenic substrate, which will directly 
disturb the cardiac rhythm. Abnormal changes in intracellular Ca2+ handling may cause 
contractile dysfunction, subcellular Ca2+ alternans and oscillations of the myocyte 
membrane potential, such as early afterdepolarizations (EADs) and delayed 
afterdepolarizations (DADs). Both EADs and DADs may evoke a number of triggered 
arrhythmias (Figure 1) potentially causing sudden cardiac death. 
 
 
Fig. 1. Delayed (DAD) and early afterdepolarization (EAD) can evoke single or sustained 
trains of action potentials. Pro-arrhythmogenic and arrhythmic events are coloured black. 
3. Triggered activity 
The term triggered activity was coined to identify and differentiate pro-arrhythmic cellular 
events triggered by a preceding action potential from spontaneous depolarization of 
abnormal automaticity. Triggered activity is caused by membrane afterdepolarizations 
classified into (1) early afterdepolarizations (EADs) and (2) delayed afterdepolarizations (DADs) 
(Wit & Rosen, 1983). EADs are abnormal depolarizing oscillations of membrane potential 
that occur during the plateau or late repolarization of an action potential, while DADs are 
depolarizing membrane potential oscillations initiated after full repolarization of the 
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triggering action potential (Figure 1). When EAD and DAD reach thresholds of depolarizing 
currents, new triggering action potentials are generated that may elicit self-sustaining 
trains of triggered activity (Figure 1). Of the different cell types in the heart, Purkinje cells 
are particularly prone to initiating afterdepolarizations, suggesting that Ca2+-dependent 
arrhythmic triggers may arise from the Purkinje fiber network (Boyden et al., 2000; 
Cerrone et al., 2007). This pro-arrhythmic behaviour is enhanced by disease-causing 
mutations in the RyR2 and greatly exacerbated by cathecholaminergic stimulation (Kang 
et al., 2010). 
3.1 Role of Ca
2+
 in EADs 
Action potential prolongation and slowing of repolarization seem to be crucial determinants 
in the initiation and facilitation of EADs. Reactivation of the L-type Ca2+ channels at 
potentials within the “Ca2+ window current” (Hirano et al., 1992; January & Riddle, 1989), or 
and re-opening of Na+ channels (Boutjdir et al., 1994) have been proposed to underlie 
synchronous changes of [Ca2+]i and upstroke of EADs. However, the concept that a change 
in membrane potential during an EAD primarily causes synchronous changes of [Ca2+]i 
throughout the cardiac myocyte has been recently re-examined. Under -adrenergic 
stimulation, spontaneous SR Ca2+ release in the form of propagating Ca2+ waves as a result 
of elevated SR Ca2+ content can also occur during the repolarizing phase of the action 
potential (Volders et al., 1997; Volders et al., 2000). This activates a Na+/Ca2+ exchanger-
dependent depolarizing current (NCX), which in an ischemic or failing heart triggers [Ca2+]i 
alternans and concomitant sudden changes in action potential duration may give rise to 
EADs and trigger extrasystoles (Xie et al., 2009). EADs appear to depend on [Ca2+]i, NCX 
current (Patterson et al., 2006) and CaMKII (Anderson et al., 1998). Increased [Ca2+]i further 
enhances L-type Ca2+ currents through the activation of CaMKII and is associated with 
transient inward currents carried by NCX.  
More recently, another type of EADs associated with immediate recurrences of atrial 
fibrillation has been described (Burashnikov & Antzelevitch, 2006; Patterson et al., 2007). 
These EADs occur at potentials more negative than that of activation of L-type Ca2+ current, 
when the combination of short action potentials (parasympathetic stimulation) and 
increased SR Ca2+ load (sympathetic stimulation) were present. Triggered action potential 
generates a massive Ca2+ release of the Ca2+ accumulated in the SR during the pause that 
exceeds the duration of action potential. Because the action potential is short, the high [Ca2+]i 
and the negative membrane potential generate NCX-mediated inward current that produces 
EADs. The most important hallmark of this type of triggered activity is that late phase 3 
EADs are triggered by a massive but essentially normal SR Ca2+ release. This differs from 
other types of triggered activity, in which DADs and other EADs occur in conditions of 
spontaneous SR Ca2+ release. Normally, EADs occur under bradycardic conditions, whereas 
DADs are more likely to occur during tachycardia or rapid pacing (reviewed by Schotten et 
al., 2011). 
3.2 Role of Ca
2+
 in DADs  
DADs typically result from abnormal increase in [Ca2+]i during diastole (Figure 2). The 
principal causes of elevated diastolic [Ca2+]i and thus, cytosolic [Ca2+] oscillations are (1) 
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increased SR Ca2+ load, (2) defective regulation of the RyR2-mediated Ca2+ release or a combination 
of both. Both alterations increase the spontaneous RyR2 open probability and SR Ca2+ leak 
and cause sufficient cytosolic [Ca2+] elevation associated with regenerative Ca2+ wave 
propagation. Ca2+ wave in turn may initiate a depolarizing Ca2+-dependent inward current 
(Iti). This transient current is largely carried by electrogenic NCX (>90% of Iti) operating in its 
forward mode; NCX current depolarizes the sarcolemma and generates DADs by extruding 
1 Ca2+ and taking up 3 Na+. If the amplitude of a DAD reaches the threshold potential for 
voltage-gated Na+ channels, a triggered action potential can result (Figure 1 and 2). This 
mechanism forms the basis for the typical rate and magnitude dependence of DADs: the 
faster is the triggering rhythm, the shorter is the interval of the triggered response and the 
faster are self-sustaining trains of DADs (Katra & Laurita, 2005). In other words, only 
spontaneous SR Ca2+ release events of sufficient magnitude and rate occurring at multiple 
sites synchronously within the cell will trigger DAD-mediated action potentials (Hoeker et 
al., 2009). The action potential initiation from a DAD is facilitated in cardiac myocytes from 
failing hearts, because of the increased expression of NCX and the reduction of repolarizing 
K+ currents as a consequence of the electrophysiological remodelling (Tomaselli & Zipes, 
2004). This implies that for any given rise in [Ca2+]i, the inward current carried by the NCX 
will be larger, and the reduction of outwardly directed K+ currents will amplify the 
depolarizing effect of a given NCX current. 
 
Fig. 2. Simplified electrophysiological mechanism underlying delayed afterdepolarization 
and triggered activity: spontaneous SR Ca2+ release (“Ca2+ leak”) through dysfunctional 
RyR2 activates NCX exchange and causes membrane positive oscillations (DADs), which 
may escalate into triggered action potentials and sustained triggered activity (adapted from 
Kockskamper & Pieske, 2006).  
4. The mechanism of triggered activity in situ 
In conditions of increased spontaneous SR Ca2+ release, which may trigger DAD-evoked 
action potentials within a single myocyte, the presence of neighbouring cardiomyocytes in 
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situ act as a current sink, which inhibits DAD generation. To produce a triggered beat and 
overcome the current sink, spontaneous Ca2+ oscillations during diastole must occur in 
multiple neighbouring cells within a fairly narrow time scale. Whereas it is now well 
accepted that neighbouring cells are the source of spontaneous Ca2+ oscillations during 
diastole (Hoeker et al., 2009; Mulder et al., 1989), the mechanisms underlying triggered 
activity in situ remain elusive. It is unknown whether spontaneous Ca2+ oscillations 
originate from the extracellular space through L-type Ca2+ channels, or from SR via RyR2, or 
perhaps from other sources (e.g. myofilaments). The concept that neighbouring cells 
collectively share the same susceptibility for Ca2+ oscillations proved unlikely, for example, 
the Ca2+ handling properties required for the synchronization of triggered activity between 
cardiomyocytes vary both from apex to base and transmurally (Katra et al., 2004; Laurita et 
al., 2003; Prestle et al., 1999). Evidence is emerging that enhanced RyR2 open probability 
increases the amplitude and temporal synchronisation of spontaneous diastolic Ca2+ release, 
despite decreased cell-to-cell coupling and therefore, increased electrical membrane 
resistance (Plummer et al., 2011). Since these experiments were conducted on intact hearts, it 
remains unresolved whether the same mechanism underlies the propagation of triggered 
action potentials in, for example, non-ischemic failing hearts. 
5. Ca
2+
-induced arrhythmias in heart failure 
Heart failure is associated with approximately 50% incidence of sudden cardiac death from 
ventricular fibrillation (Packer, 1985; Packer et al., 1999). A substantial body of evidence has 
accumulated demonstrating that acquired alterations in Ca2+ homeostasis lead to DADs in 
heart failure (reviewed by Pogwizd et al., 2001). Changes in Ca2+ handling, structural and 
electrophysiological remodelling are thought to account for abnormalities of excitation-
contraction coupling and the susceptibility for cardiac arrhythmias, as well as to the reduced 
contractile force, prolongation of relaxation and the negative force-frequency relationship. 
The fundamental changes in Ca2+ handling that occur with heart failure are (1) increased 
NCX function resulting in increased removal of Ca2+ from the cytosol and larger 
depolarizing current and (2) the concurrently decreased inward rectifier K+ current resulting 
in an even larger depolarisation; (3) reduced SR Ca2+ uptake due to decreased SERCA2a 
expression and reduced phosphorylation of phospholamban, (4) altered regulation of the 
RyR2 due to increased RyR2 phosphorylation associated with a decreased threshold for SR 
Ca2+ release (Trafford et al., 2000b) and (5) decreased -adrenergic responsiveness, but 
increased -adrenergic drive, which increases SR Ca2+ load (Desantiago et al., 2008). In 
heart failure, however, Ca2+ waves and DADs occur at reduced SR Ca2+ content. It is the 
adrenergic stimulation that is thought to increase SR Ca2+ load above the threshold required 
for triggered activity. Indeed, experimental findings from atrial and ventricular myocytes 
from failing hearts are consistent with enhanced SR Ca2+ loading associated with 
spontaneous SR Ca2+ release. The seemingly conflicting observation is that Ca2+-dependent 
arrhythmias are more prevalent in heart failure due to enhanced diastolic SR Ca2+ release 
(Pogwizd et al., 2001), despite the decrease of SR Ca2+ content (Kubalova et al., 2005). To 
explain this dichotomy, Sobie et al. (2006) proposed an interesting hypothesis using a 
mathematical model based on the recent experimental findings. Their model predicts that 
(1) “rogue RyR2”3 can operate almost invisibly to produce a fraction of the overall Ca2+ leak 
and (2) coupled gating between clustered RyR2s is disrupted in response to physiologic 
                                                 
3 (unclustered) RyR2s in the SR membrane that are not part of RyR2 clusters 
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phosphorylation or excessive phosphorylation of RyR2s in disease states such as heart 
failure. 
Defects in RyR2 regulation may also contribute to triggered activity and arrhythmogenesis 
in patients with atrial arrhythmias. Atrial fibrillation, the most common human cardiac 
arrhythmia, occurs in up to 30-40% of patients with heart failure (Cleland et al., 2003). 
Defects in Ca2+ release from the SR during diastole has been reported to be the mechanism 
underlying greater arrhythmogenic susceptibility in patients with atrial fibrillation (Hove-
Madsen et al., 2004; Neef et al., 2010). Generation of transgenic mice harbouring a gain-of-
function in the RyR2 has proven to be a valuable tool in unravelling molecular mechanisms 
causing atrial fibrillation. For instance, in RyR2R176Q+/- mice spontaneous atrial fibrillation 
was absent at rest but inducible by rapid atrial pacing, which also resulted in increased 
CaMKII phosphorylation of the RyR2 (Chelu et al., 2009). This implies that Ca2+ leak either 
through phosphorylated or defective RyR2 alone, might not be enough to produce atrial 
fibrillation. Both increased CaMKII activity and an arrhythmogenic substrate (e.g., RyR2 
mutation) are elementary to produce atrial ectopy. 
6. SR Ca
2+
 overload - a trigger for spontaneous SR Ca
2+
 release 
The amount of Ca2+ within the SR is a critical regulator of contraction during normal 
excitation-contraction coupling. -adrenergic stimulation, digitalis intoxication, rapid pacing 
and increased extracellular Ca2+ are conditions that increase inotropy by increasing SR Ca2+ 
content. When the amount of Ca2+ in the SR excessively increases, a phenomenon known as 
SR Ca2+ overload (Trafford et al., 1997; Trafford et al., 2001), a regenerative Ca2+ release and 
arrhythmia may occur. SR Ca2+ overload is a consequence of an imbalance between Ca2+ 
influx and efflux. This disequilibrium may evolve from (1) the reduced Ca2+ efflux (primarily 
due to increased NCX current in forward mode), (2) increased SR Ca2+ uptake (due to 
increased phosphorylation of phospholamban and/or SERCA2a expression), (3) increased 
Ca2+ influx across the sarcolemma (primarily due to increased L-type Ca2+ current), and (4) 
altered SR Ca2+ buffering capacity (due to a calsequestrin mutation).SR Ca2+ overload typically 
results in spontaneous SR Ca2+ release via RyR2. As opposed to the “silent” Ca2+ leak 
through rogue (or unclustered) RyR2 (Sobie et al., 2006), the diastolic Ca2+ leak via clustered 
RyR2 can be experimentally visualized as increased Ca2+ spark frequency, which, when high 
enough in a given volume of the cell, can initiate a Ca2+ wave. Once the Ca2+ wave has been 
initiated, the propagation of Ca2+ wave will largely depend on the amount of SR Ca2+ 
content. The greater the SR Ca2+ content, the more likely a Ca2+ wave is to propagate (Cheng 
et al., 1996) and trigger DAD. To distinguish spontaneous Ca2+ release due to the elevated 
SR Ca2+ load from depolarisation-initiated Ca2+ release, Wayne Chen’s group coined the 
term store overload-induced Ca2+ release (SOICR) (Jiang et al., 2004). SOICR occurs when the 
threshold level for Ca2+ retention by RyR2 is exceeded. In addition to the SR Ca2+ content, 
the threshold is also determined by the properties of RyR2. For instance, the application of 
low dose caffeine, which increases the open probability of the RyR2 (Rousseau & Meissner, 
1989), decreases the threshold and increases diastolic SR Ca2+ leak (Trafford et al., 2000b). 
On the other hand, tetracaine, which decreases RyR2 opening (Gyorke et al., 1997; Xu et al., 
1993), increases threshold and decreases SR Ca2+ leak (Overend et al., 1997). Thus, 
modulation of RyR2 may have a significant impact on the properties of SOICR and therefore 
on the occurrence of DADs and triggered arrhythmias, while sustained impact on Ca2+-
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induced Ca2+ release is unlikely. Based on these observations, (Trafford et al., 2000b) 
proposed the “SR Ca2+ auto-regulation” hypothesis, which predicts that increased open 
probability of the RyR2 only transiently enhances spontaneous SR Ca2+ release, because of 
SR luminal Ca2+ regulation. Changes in RyR2 activity are compensated for by the SR Ca2+ 
content, implying that increased release reduces the steady-state SR Ca2+ content and 
consequently spontaneous Ca2+ release. 
7. Arrhythmias triggered by dysfunctional SR Ca
2+
 handling 
7.1 Catecholaminergic polymorphic ventricular tachycardia (CPVT) 
Abnormalities of intracellular Ca2+ regulation caused by dominant mutations in the RyR2 
gene (Priori et al., 2001) and by recessive mutations in the calsequestrin gene (Lahat et al., 
2001), encoding SR Ca2+ binding protein (calsequestrin 2), may account for malignant 
catecholamine-induced polymorphic ventricular arrhythmias (CPVT) (Priori et al., 2001; 
Swan et al., 1999). CPVT occurs suddenly and unexpectedly in young and otherwise healthy 
individuals under emotional stress or physical exercise (e.g. increased catecholaminergic 
stimulation). Known RyR2 and calsequestrin mutations account for approximately 50-60% 
and 1-2% of CPVT mutations, respectively (Cerrone et al., 2009). Causes for the remaining 
CPVT mutations have yet to be identified. Even prior to the linkage of RyR2 mutations and 
CPVT, the striking similarity between ECG patterns (bidirectional or polymorphic 
ventricular tachycardia) observed in CPVT patients and digitalis-induced arrhythmias in 
patients with digitalis-intoxication, led to the hypothesis that arrhythmias in CPVT were 
most likely initiated by SR Ca2+ overload and consequently by DADs and triggered activity 
(Leenhardt et al., 1995). 
7.1.1 RyR2 mutations 
Generation of genetically modified mouse models has advanced our understanding of 
mechanisms of both autosomal-dominant and recessive CPVT. The first CPVT transgenic 
mouse model with a gain-of-function defect in the RyR2 was generated by the Priori group 
(Cerrone et al., 2005). The introduction of the RyR2R4496C+/- mutation reliably reproduced the 
human phenotype. On exposure to isoproterenol (-adrenergic agonist), this mouse model 
produced DADs and triggered activity underlying CPVT (Liu et al., 2006). Subsequent 
studies using other transgenic mouse models (Kannankeril et al., 2006; Lehnart et al., 2008; 
Uchinoumi et al., 2010) confirmed that RyR2 mutations modify intracellular Ca2+ regulation 
through an increased SR Ca2+ leak as a result of increased RyR2 open probability at resting 
conditions (Jiang et al., 2005). It is this increased SR Ca2+ leak that accounts for the increased 
propensity of DAD-mediated triggered activity. Lowered threshold due to the increased 
Ca2+ sensitivity to luminal and/or cytosolic Ca2+ has been attributed for the elevated 
propensity to arrhythmias in the RyR2R4496C+/- mutant (Fernandez-Velasco et al., 2009; Jiang 
et al., 2005). The decreased threshold may explain why mice expressing the RyR2 mutation 
are more likely to develop Ca2+ waves and DADs. However, neither mice nor patients with 
CPVT develop arrhythmias at rest. Faster heart rate and SR Ca2+ uptake during -adrenergic 
stimulation is the physiological trigger, which increases SR Ca2+ load and subsequent Ca2+ 
waves followed by DAD-mediated triggered beats in ventricular cardiomyocytes 
harbouring RyR2 mutations (Kannankeril et al., 2006; Lehnart et al., 2008; Liu et al., 2006). 
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This raises the question as to why -adrenergic stimulation is required to produce CPVT. -
adrenergic stimulation has been reported to produce Ca2+ waves by increasing the SR Ca2+ 
content and not by decreasing the threshold for SR Ca2+ release (Kashimura et al., 2010). -
adrenergic stimulation even increased the threshold for spontaneous SR Ca2+ release 
independent of SERCA2a activity in both wild-type and RyR2R4496C+/- cardiac myocytes, 
suggesting the reduced rather than increased arrhythmogenic potential for Ca2+-dependent 
arrhythmias. This does not exclude the possibility that different RyR2 mutations respond 
differently to -adrenergic stimulation, indicating diverse implications on the severity of the 
phenotype. For instance, it has been reported that the RyR2R2474+/- mutation renders the 
RyR2 more sensitive to adrenergic stimulation by destabilizing interdomain interaction 
within RyR2 (Uchinoumi et al., 2010). Such a defect could lower the SR Ca2+ threshold, so 
that enhanced SR Ca2+ uptake induced by -adrenergic stimulation causes the level of free 
Ca2+ to overshoot its lowered SOICR threshold (Priori & Chen, 2011). Importantly, triggered 
activity in RyR2R4496C+/- cardiomyocytes does occur in the absence of -adrenergic 
stimulation, if SR Ca2+ content is increased by ouabain, a cardiac glycoside with Na+/K+-
ATPase inhibiting effect. Ouabain elevates cytosolic [Na+] and thus, indirectly elevates SR 
Ca2+ load through the reverse mode of NCX and, in contrast to wild-type cardiac myocytes, 
massively increases the occurrence of DADs and triggered action potentials in RyR2R4496C+/- 
cardiomyocytes (Sedej et al., 2010). The finding that increased SR Ca2+ content (in the 
absence of catecholamines) suffices to induce arrhythmogenic events in mouse 
cardiomyocytes with a human CPVT mutation (Sedej et al., 2010), inspired Brette (2010) to 
give CPVT a new name: Calcium polymorphic ventricular tachycardia. Taken together, these 
findings highlight the importance of SR Ca2+ content in the CPVT arrhythmogenesis. 
7.1.2 Calsequestrin 2 mutations 
The recessive forms of CPVT due to the calsequestrin gene mutation (casq) are found in 
approximately 1-2% of CPVT patients (Cerrone et al., 2009). Calsequestrin is an intra-SR 
Ca2+ binding protein, which plays a pivotal role in regulating SR Ca2+ release by (1) 
increasing the SR luminal total Ca2+ content through its low Ca2+ binding affinity, (2) 
buffering free Ca2+ levels in the SR lumen, and (3) regulating SR Ca2+ release either through 
the direct (MacLennan & Chen, 2009) or indirect interaction with RyR2 (calsequestrin-
triadin-junction complex) (Gyorke & Terentyev, 2008; Qin et al., 2008). Reduced levels of 
calsequestrin may result in rapid recovery of SR free Ca2+ after each Ca2+ release and a 
potentially higher level of SR free Ca2+ during a sudden increase in SR Ca2+ loading (e.g., -
adrenergic stimulation). The common hallmark of all calsequestrin-associated CPVT 
mutations is decreased luminal Ca2+ binding and Ca2+ buffering resulting in increased 
luminal free Ca2+, which exceeds the normal threshold for SOICR. In turn, this increases the 
propensity for SR Ca2+ release from the overloaded SR and evokes DADs and triggered 
activity. Studies on casq-/- null mice and humans showed that calsequestrin is not critical for 
normal RyR2 regulation under resting conditions, since excitation-contraction coupling 
appeared normal and arrhythmias were not observed under basal conditions. However, the 
administration of isoproterenol increased the SR Ca2+ leak, which was proportional to the 
calsequestrin loss, indicating that calsequestrin’s primary role is a ”molecular brake” that 
prevents spontaneous Ca2+ release at high SR Ca2+ load (Chopra et al., 2007). Taken together, 
calsequestrin-induced CPVT and RyR2-mediated CPVT share a common causal 
arrhythmogenic mechanism involving disruption of Ca2+ homeostasis. 
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8. Molecular mechanisms underlying increased SR Ca
2+
 leak 
At present many aspects of the molecular mechanisms by which RyR2 mutations alter the 
physiological RyR2 properties in acquired (e.g. heart failure) and congenital triggered 
arrhythmias (e.g. CPVT) remain controversial. However, an increase in Ca2+ leak from the 
SR via RyR2 is the unifying phenomenon for heart failure and CPVT. The concept that 
arrhythmias occur due to increased Ca2+ sensitivity (and thus, lower threshold) of the RyR2 
at luminal or cytosolic sites has emerged.  
8.1 Increased sensitivity of RyR2 to luminal or cytosolic Ca
2+
 activation 
Spontaneous SR Ca2+ release occurs when the SR Ca2+ content reaches threshold (Dibb et al., 
2007), suggesting that luminal Ca2+ concentration affects RyR2 opening and modulates the 
amount of Ca2+ released from the SR during SR Ca2+ overload. Indeed, increasing luminal 
Ca2+ elevates RyR2 open probability and increases RyR2 sensitivity to Ca2+ leading to 
spontaneous SR Ca2+ release (SOICR) (Fernandez-Velasco et al., 2009; Jiang et al., 2004; Jiang 
et al., 2005). SR Ca2+ release increases in nonlinear accelerating fashion with increasing SR 
luminal Ca2+ concentration (Trafford et al., 2000a). This nonlinear relationship implies that 
SR Ca2+ release is not passively driven by a Ca2+ concentration gradient and raises the 
question, whether other mechanisms beside the luminal SR Ca2+ concentration may also 
trigger RyR2 activity. 
Numerous CPVT-linked RyR2 mutations expressed in heterologous cells as well as native 
cardiomyocytes preferentially sensitize the RyR2 to luminal Ca2+ activation (Jiang et al., 
2004; Jiang et al., 2005; Jones et al., 2008). Consequently, the threshold luminal Ca2+ level 
required for triggering SOICR is reduced and susceptibility for SOICR increased. 
However, few RyR2 mutations affects both the response of the RyR2 to cytosolic and 
luminal Ca2+ concentration (Fernandez-Velasco et al., 2009; Jiang et al., 2004; Jones et al., 
2008). Despite the increased sensitivity to both cytosolic and luminal Ca2+ concentration, 
Ca2+-induced Ca2+ release in cardiomyocytes harbouring CPVT RyR2 mutations is at 
resting conditions little, if at all, affected (Mohamed et al., 2007). This can be explained by 
the “SR Ca2+ auto-regulation” hypothesis (Trafford et al., 2000a). SR Ca2+ content 
counterbalances defective luminal or cytosolic Ca2+ activation of the RyR2. For instance, 
increased SR Ca2+ release due to enhanced luminal or cytosolic Ca2+ activation will lead to 
reduced SR Ca2+ load, which will counteract increased Ca2+ release propensity from the 
SR (auto-regulation). Altered Ca2+ activation of RyR2 will have only a transient effect on 
Ca2+-induced Ca2+ release under resting conditions and lead to a new steady-state within 
few heartbeats. In conditions above the critical SR Ca2+ load (e.g., emotional stress, 
physical exercise, -adrenergic stimulation in heart failure), the “SR Ca2+ auto-regulation” 
fails to prevent cardiomyocytes from SOICR, the trigger of DADs and triggered 
arrhythmias. Taken together, it is the increase in SR Ca2+ content what renders the SR Ca2+ 
leak uncontrolled. 
To explain lower threshold for SOICR release, two mechanisms have been proposed and 
they will be presented below: (1) excessive RyR2 phosphorylation linked with the 
FKBP12.6 dissociation from the RyR2 complex and (2) weaker interdomain interactions 
within RyR2. 
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8.1.1 FKBP12.6 unbinding hypothesis (increased RyR2 phosphorylation) 
RyR2 forms a macromolecular complex with numerous proteins on the SR luminal side (e.g., 
triadin, junctin, calsequestrin) as well as the cytosolic side (e.g., calmodulin, FKBP12.6), just 
to name a few. In addition, two main kinases are also part of the RyR2 complex involved in 
RyR2 phosphorylation: protein kinase A (PKA), activated by β-adrenergic stimulation, and 
CaMKII, activated by increased cytosolic Ca2+ turnover (e.g. increased heart rate). These 
proteins provide different regulatory modalities to control RyR2 open probability. 
Disruption of critical protein-protein interactions within the RyR2 macromolecular complex 
may alter the sensitivity of the RyR2 to Ca2+ activation. For instance, stabilization of the 
RyR2 is thought to depend on the 12.6. kDa FK506-binding protein (FKBP12.6 or calstabin 
2). This protein prevents aberrant activation of the RyR2 during the diastole. The 
dissociation of FKBP12.6 from RyR2 as a result of a RyR2 mutation or phosphorylation of 
RyR2 by PKA during -adrenergic stimulation has been shown to increase the sensitivity of 
the RyR2 to cytosolic Ca2+ activation (Lehnart et al., 2008; Marx et al., 2000; Wehrens et al., 
2003). In other words, RyR2 mutations or the “hyperadrenergic” state as often seen in heart 
failure make the RyR2 channel leaky and increase the susceptibility for the initiation and 
propagation of Ca2+ waves. These findings led to the paradigm that impaired binding of 
FKBP12.6 to RyR2 is a common final pathway for arrhythmogenesis in CPVT and heart 
failure (Wehrens et al., 2003). However, other studies failed to reproduce these findings. 
Furthermore, in later studies the same CPVT RyR2 mutations showed either no effect on 
FKBP12.6 binding (George et al., 2003; Jiang et al., 2005; Liu et al., 2006) or even increased 
binding affinity of FKBP12.6 for the RyR2 (Tiso et al., 2002). Recent evidence even suggests 
that PKA is not involved in the dissociation of FKBP12.6 from RyR2, thus questioning the 
causality between RyR2 phosphorylation and FKBP12.6 dissociation (Guo et al., 2010). 
8.1.2 Domain unzipping hypothesis (weaker interdomain interaction)  
Proper folding of the RyR2 relies on intimate intermolecular interaction between RyR2 
domains. These domain interactions are believed to stabilize and maintain the closed state of 
the RyR2 channel (Ikemoto & Yamamoto, 2000), suggesting a close mechanistic similarity 
between PKA-mediated FKBP12.6 dissociation and domain-domain interaction within the 
RyR2 channel (Ikemoto & Yamamoto, 2002). For example, defective RyR2 interdomain 
interactions (also called domain unzipping) between the N-terminal domain and central 
domain in the context of RyR2 mutations weaken this interaction and destabilize the closed 
state of the RyR2 (Ikemoto & Yamamoto, 2000; Tateishi et al., 2009). Weakening of these 
interdomain interactions occurs transiently on a beat-to-beat basis during excitation-
contraction coupling, but permanently in both CPVT-associated RyR2 mutations and in 
pacing-induced failing hearts (Oda et al., 2005). Destabilisation of the zipped state may alter 
the sensitivity of RyR2 to luminal or cytosolic Ca2+ and contribute to abnormal SR Ca2+ leak. 
Although the majority of the reported CPVT mutation sites are within the N-terminal and 
central domain, it is possible that ”domain unzipping” also affects less conserved regions of 
RyR2 mutations associated with CPVT. It has been demonstrated that, depending on the 
location of the RyR2 mutation, a distinct pattern of conformational instability in Ca2+ 
handling and interdomain interaction is introduced. This suggests that the mutational locus 
may be an important mechanistic determinant of Ca2+ release channel dysfunction in 
arrhythmia and sudden cardiac death (George et al., 2006). 
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Fig. 3. Hypothetical mechanisms of acquired (e.g. heart failure) and inherited RyR2 
dysfunction (e.g. CPVT): (1) domain unzipping and (2) FKBP12.6 unbinding due to enhanced 
RyR2 phosphorylation. Both RyR2 aberrations increase the sensitivity of the RyR2 and lower 
the threshold for SR Ca2+ release. The maintenance of increased SR Ca2+ load during, for 
example, -adrenergic stimulation is considered a major determinant for the sustained 
spontaneous Ca2+ release from the SR and arrhythmogenesis. If SR Ca2+ content is normal, a 
transient diastolic SR Ca2+ release will occur. 
9. Normalizing RyR2 function prevents triggered arrhythmias 
After the discovery that mutations in the RyR2 gene underlie Ca2+ homeostasis disturbances 
associated with CPVT (Laitinen et al., 2001; Priori et al., 2001), important insights into novel 
and specifically tailored therapies that may target the common pathway underlying CPVT 
and heart failure have emerged. Recent studies suggest the usage of therapeutic approaches 
that should combine two actions: (1) suppression of SR Ca2+ overload and (2) stabilization of the 
RyR2 dysfunction by reducing the RyR2 open probability and thence, increasing the SR 
threshold. Such therapeutic actions might together effectively prevent RyR2-mediated SR 
Ca2+ leak in CPVT carriers, whereas RyR2 stabilization alone might be sufficient in heart 
failure patients. A novel class of drugs - RyR2 stabilisers - that has attracted much attention 
in the past few years and will remain the subject of intensive investigations include K201, 
dantrolene and flecainide. 
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9.1 K201 (or JTV-519) 
K201 is the 1, 4-benzothiazepine derivative that was initially developed to prevent Ca2+ 
overload-induced myocardial infarction and sudden cardiac cell death (Kaneko et al., 1997). 
As shown in Table 1, K201 has been reported to have various actions at multiple sites in the 
cardiomyocyte, including non-specific multi-ion channel blocking effect (Kimura et al., 1999; 
Nakaya et al., 2000) and inhibition of SERCA (Loughrey et al., 2007). Most important is the 
finding that K201 stabilizes RyR2 and suppresses SR Ca2+ leak by increasing the binding 
affinity for the FKBP12.6 to RyR2 (Wehrens et al., 2004). Recent studies, however, 
demonstrated that FKBP12.6 may not be involved in regulation of Ca2+ release from the SR, 
since loss of FKBP12.6 failed to increase RyR2-mediated spontaneous Ca2+ release and 
stress-induced ventricular arrhythmias (Guo et al., 2010; Xiao et al., 2007). K201 binds to the 
central region of RyR2 (Yamamoto et al., 2008), thereby inducing a rapid conformational 
change in RyR2 correcting defective channel gating of RyR2 independent of RyR2 
phosphorylation (Yano et al., 2003). The closed state of RyR2 prevents SR Ca2+ leak and 
propagation of spontaneous Ca2+ waves independent of FKBP12.6 association (Hunt et al., 
2007; Yamamoto et al., 2008). K201 effects are dose-dependent and concentrations up to 1 
M ensure RyR2-mediated action (Table 1). K201 prevented ventricular arrhythmias in 
FKBP12.6-deficient mice (Wehrens et al., 2004), but failed to prevent DADs and ventricular 
tachycardia induced by isoproterenol and caffeine in a CPVT mouse model carrying a 
human RyR2R4496C+/- mutation (Liu et al., 2006). On the other hand, pre-treatment with K201 
massively reduced triggered activity evoked by ouabain-induced SR Ca2+ overload in the 
RyR2R4496C+/- cardiomyocytes (Sedej et al., 2010). Taken together, it is still unclear whether 
K201 exerts its antiarrhythmic effects specifically through stabilization of the RyR2 or 
through synergistic inhibitory actions on sarcolemmal ion currents or by any other 
additional action(s). Nevertheless, K201 appears a suitable prototype for development of 
compounds that more specifically target RyR2, such as S107, a more specific RyR2 stabilizer 
(Lehnart et al., 2008). 
9.2 Dantrolene 
Emerging evidence suggests that defective interdomain interactions within RyR2 play a key 
role in abnormal channel gating of RyR2 in failing hearts and RyR2 mutations (Kobayashi et 
al., 2009; Oda et al., 2005). Therefore, correction of the defective interdomain interaction may 
represent a new therapeutic strategy against heart failure and possibly cardiac arrhythmia. 
Dantrolene has been primarily used to treat acute malignant hyperthermia by targeting 
skeletal muscle RyR1. Recently, dantrolene has been also found to bind to domain 601-620 of 
RyR2 and reduce abnormal SR Ca2+ leak by correcting defective interdomain interaction 
within RyR2 in pacing-induced heart failure. As a result, DADs and Ca2+ spark frequency 
are reduced (Kobayashi et al., 2005; Kobayashi et al., 2009). Pre-treatment with dantrolene 
prevents both ventricular arrhythmia induced by either epinephrine or exercise in 
RyR2R2474S+/- knock-in mouse model for human CPVT (Kobayashi et al., 2010). Dantrolene 
also improves contractile function in dogs after pacing-induced heart failure (Kobayashi et 
al., 2009). Importantly, dantrolene has no appreciable effect on normal SR and cardiac 
function, indicating that dantrolene may be effective for stabilizing RyR2 merely in the 
unzipped state. 
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K201 
concentration/ 
duration of 
intervention  
Animal 
model,origin 
of cells 
In vivo effect In vitro effect References 
1-10 M acute Guinea-pig, 
Ventricle 
no data Frequency and voltage-dependent 
inhibition of Na+, Ca2+, K+ 
currents, reduced action potential 
duration 
(Kimura et al., 
1999; Kiriyama 
et al., 2000) 
1 M acute Guinea-pig, 
Atrium 
inhibition of 
atrial 
fibrillation  
Inhibition of the muscarinic 
acetylcholine-receptor operated K 
current, delayed rectifier K+ 
current, prolonged action potential 
duration 
(Nakaya et al., 
2000) 
1 and 3 M  
(2-3 min) 
Rabbit, 
Ventricle 
no data inhibition of RyR2 and SERCA 
reduced diastolic Ca2+ release, 
reduction of Ca2+ wave velocity 
and frequency, unchanged SR Ca2+ 
content and L-type Ca2+-current, 
K201 effect  
FKBP12.6-independent 
(Loughrey et 
al., 2007) 
0.5 mg/kg/h  
(1 week)  
1 M  
(2h pre-incubation)
Mouse, 
FKBP12.6+/- 
Ventricle 
No exercise-
induced 
ventricular 
tachycardia & 
sudden death 
reduced inward transient  
current (Iti),  
K201 effect  
FKBP12.6-dependent 
(Lehnart et al., 
2006; Wehrens 
et al., 2004) 
0.5 mg/kg/h  
(1 week) 
1 M and 10 M 
(acute) 
Mouse, 
RyR2R4496C+/- 
Ventricle 
CPVT isoproterenol-induced triggered 
activity  
(Liu et al., 
2006) 
1 M  
(1h pre-
incubation) 
Mouse, 
RyR2R4496C+/- 
Ventricle 
no data reduced ouabain-evoked triggered 
activity (DAD and triggered AP 
frequency) 
(Sedej et al., 
2010) 
1-10 M Rat, Ventricle
HEK-293 cells
no data no SR Ca2+ leak,  
K201 effect  
FKBP12.6-independent 
(Hunt et al., 
2007) 
0.5 mg/kg/h  
(1, 4 weeks) 
1 M (acute) 
Dog, HF 
model, SR 
vesicles 
no data no SR Ca2+ leak, normal PKA 
phosphorylation,  
K201 effect FKBP12.6-dependent 
(Kohno et al., 
2003) 
0.3 M Dog, HF 
model, SR 
vesicles and 
ventricle 
no data no SR Ca2+ leak, reduced Ca2+ 
spark frequency 
(RyR2 mutations mimicked using 
synthetic peptides) 
(Tateishi et al., 
2009) 
1 M Dog, MI 
model, 
Purkinje cells 
no data reduced micro Ca2+ waves (Boyden et al., 
2004) 
0.5 mg/kg/h  
(4 weeks) 
Dog, HF 
model,  
SR vesicles 
no data no SR Ca2+ leak, normal PKA 
phosphorylation,  
K201 effect FKBP12.6-dependent 
(Yano et al., 
2003) 
Abbreviations: HEK-293= human embryonic kidney cell line 293, HF= heart failure, PKA= protein 
kinase A, RV= right ventricle, SR= sarcoplasmic reticulum, MI= myocardial infarction 
Table 1. K201 effects on triggered activity in different animal models 
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9.3 Flecainide 
In analogy with the local anaesthetic-tetracaine, flecainide is effective in suppressing 
spontaneous SR Ca2+ release by directly inhibiting RyR2 activity in mice and in humans 
with calsequestrin-associated CPVT (Watanabe et al., 2009) and murine Purkinje cells 
harbouring RyR2R4496C+/- mutation (Kang et al., 2010). This effect has been attributed to the 
reduced duration of channel openings without affecting closed channel duration and net 
spark-mediated Ca2+ leak (Hilliard et al., 2010). Thus, flecainide directly targets the 
molecular defect responsible for arrhythmogenic Ca2+ waves that trigger exercise- and 
catecholamine-induced polymorphic ventricular arrhythmias. In combination with 
flecainide’s Na+-channel inhibition, which reduces the rate of triggered activity, flecainide 
seems to be a safe and effective therapy in the majority of CPVT patients who suffer from 
exercise-induced ventricular arrhythmias (van der Werf et al., 2011). Given the rare onset of 
CPVT episodes and different causality of fatal arrhythmias (exercise-independent), further 
long-term follow-up clinical studies are required to justify the use of flecainide in preventing 
fatal arrhythmias in CPVT patients. Collectively, blocking the RyR2 open state has emerged 
as a new promising therapeutic strategy to prevent Ca2+ wave propagation during diastole. 
9.4 CaMKII inhibition 
In heart failure, the expression and activity of CaMKII are increased (Hoch et al., 1999; 
Kirchhefer et al., 1999). Chronic activation of CaMKII phosphorylates common Ca2+ regulatory 
proteins with PKA, including L-type voltage-gated Ca2+ channels, phospholamban and RyR2 
(Ji et al., 2003). The increased L-type Ca2+ current may facilitate Ca2+ window currents (Dzhura 
et al., 2000) and trigger EADs, whereas CaMKII phosphorylation of RyR2 increases the 
sensitivity to Ca2+-dependent activation and the frequency of Ca2+ sparks (Guo et al., 2006). 
Such effects may enhance diastolic SR Ca2+ release and trigger DADs, despite reduced SR Ca2+ 
content (Chelu et al., 2009; Maier et al., 2003; Wu et al., 2002). A CaMKII inhibitor, KN-93, 
effectively blocks both EADs (Anderson et al., 1998) and DADs resulting from enhanced 
diastolic SR Ca2+ leak and Ca2+ waves in an arrhythmogenic rabbit model of non-ischemic 
heart failure (Ai et al., 2005; Curran et al., 2010). 
CaMKII activation and Ca2+ handling abnormalities have been reported to play a major role 
in the vicious cycle of arrhythmogenesis promotion and mechanical dysfunction that 
characterizes electrical storm4 . Infusion of a calmodulin antagonist W-7 to a rabbit model of 
electrical storm reduces CaMKII hyperphosphorylation, suppresses ventricular tachycardia 
or fibrillation, and rescues left ventricular dysfunction (Tsuji et al., 2011).  
CaMKII activity also increases during exercise in healthy individuals and may play a role in 
CPVT (Kemi et al., 2005; Rose & Hargreaves, 2003). Genetic overexpression of CaMKII in a 
CPVT mouse model with a gain-of-function RyR2 mutation (R4496C) causes increased 
diastolic SR Ca2+ leak, DADs and fatal ventricular arrhythmias (Dybkova et al., 2011), 
whereas acute CaMKII inhibition in the same CPVT mouse model prevents arrhythmias 
(Liu et al., 2011). Acute CaMKII inhibition has also been proven to be beneficial in treating 
atrial arrhythmias induced by rapid pacing in CPVT mice with another RyR2 mutation 
(R176Q). These mice showed increased susceptibility to atrial fibrillation induction due to 
CaMKII-mediated increase in RyR2-dependent Ca2+ leak (Chelu et al., 2009). Consistent with 
                                                 
4 defined as 3 or more episodes of ventricular tachycardia or fibrillation in a 24-hour period  
www.intechopen.com
 
Mechanisms of Ca
2+
–Triggered Arrhythmias 
 
173 
these findings, CaMKII inhibition completely reverses the effects of overexpressed miR-15 
(also in the presence of -adrenergic activation), a small muscle-specific noncoding 
microRNA, which increases the diastolic SR Ca2+ leak and reduces SR Ca2+ content 
(Terentyev et al., 2009). 
It is important to distinguish the specificity of the CaMKII-dependent targets contributing to 
arrhythmias from other CaMKII-dependent physiological pathways. However, it is 
becoming increasingly clear that CaMKII inhibitors reduce RyR2 sensitivity to Ca2+ and 
thereby, restore the threshold for spontaneous SR Ca2+ release to a normal or even higher 
level. Taken together, confirming these findings with pharmacologic targeting of RyR2 in 
conjunction with selected CaMKII signalling might be a promising target for the treatment 
of cardiac arrhythmias, such as heart failure, CPVT and electrical storms. 
10. Conclusion  
Since the discovery that mutations in the RyR2 gene underlie Ca2+ homeostasis disturbances 
associated with CPVT, important new insights have been obtained into the molecular 
mechanisms underlying Ca2+-triggered atrial and ventricular arrhythmias. Increased 
sensitivity of the RyR2 and lowered threshold for the spontaneous SR Ca2+ leak have 
emerged as causal arrhythmogenic mechanisms linking acquired and congenital 
arrhythmias in patients with heart failure and CPVT, respectively. The emerging evidence 
that inhibition of CaMKII reduces RyR2 sensitivity to Ca2+ and restores the threshold for 
spontaneous SR Ca2+ release has paved the way to move from bench to bedside. Selected 
targeting of RyR2 in conjunction with CaMKII signalling might be a promising target for the 
treatment of Ca2+-triggered arrhythmias. 
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